Evidence map›Paper›PMID 25229719›Full record

ArticleNeuropharmacology2015

Nucleus accumbens shell excitability is decreased by methamphetamine self-administration and increased by 5-HT2C receptor inverse agonism and agonism.

Steven M Graves, Mary J Clark, John R Traynor, Xiu-Ti Hu, T Celeste Napier

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. The 5-HTPharmacology research & perspectives · 2021
    Trial
  2. Article
  3. Article
  4. Matrix Metalloproteinase-9 Signaling Regulates Colon Barrier Integrity in Models of HIV Infection.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Lateral Habenula 5-HTInternational journal of molecular sciences · 2021
    Article
  10. Article
  11. Article
  12. AMPA receptor and metabotropic glutamate receptor 1 adaptations in the nucleus accumbens core during incubation of methamphetamine craving.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  13. Review
  14. Methamphetamine decreases KJournal of neurochemistry · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. The serotonin 5-HTJournal of psychopharmacology (Oxford, England) · 2017
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Steven M GravesDepartment of Pharmacology, Center for Compulsive Behavior and Addiction, Rush University Medical Center, 1735 W Harrison St, Cohn Research Building Chicago, IL 60612, USA.
Mary J ClarkDepartment of Pharmacology, Substance Abuse Research Center University of Michigan, 1150 W Medical Center Drive, Medical Science Research Building III Ann Arbor, MI 48109, USA.
John R TraynorDepartment of Pharmacology, Substance Abuse Research Center University of Michigan, 1150 W Medical Center Drive, Medical Science Research Building III Ann Arbor, MI 48109, USA.
Xiu-Ti HuDepartment of Pharmacology, Center for Compulsive Behavior and Addiction, Rush University Medical Center, 1735 W Harrison St, Cohn Research Building Chicago, IL 60612, USA.
T Celeste NapierDepartment of Pharmacology, Center for Compulsive Behavior and Addiction, Rush University Medical Center, 1735 W Harrison St, Cohn Research Building Chicago, IL 60612, USA; Department of Psychiatry, Rush University Medical Center, 2150 W Harrison St Chicago, IL 60612, USA. Electronic address: Celeste_Napier@rush.edu.
University of Michigan–Ann Arbor · USRush University · US

Funding

5-HT &Medication Development for Methamphetamine AbuseR01DA015760 · NIDA · RUSH UNIVERSITY MEDICAL CENTER · PI NAPIER, T. CELESTE · 2003 to 2007
$1.7M
Cellular Mechanisms in Animal Models of DepressionR01MH083754 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TRAYNOR, JOHN R. · 2011 to 2011
$386k
5HT receptors, neuronal plasticity, and methamphetamine-induced place perference.F31DA024923 · NIDA · RUSH UNIVERSITY MEDICAL CENTER · PI GRAVES, STEVEN MICHAEL · 2009 to 2011
$108k
NIDA NIH HHS DA015760NIDA NIH HHS DA024923NIDA NIH HHS F31 DA024923NIDA NIH HHS R01 DA015760NIMH NIH HHS MH083754NIMH NIH HHS R01 MH083754
6 · The paper itself

Abstract

Methamphetamine profoundly increases brain monoamines and is a widely abused psychostimulant. The effects of methamphetamine self-administration on neuron function are not known for the nucleus accumbens, a brain region involved in addictive behaviors, including drug-seeking. One therapeutic target showing preclinical promise at attenuating psychostimulant-seeking is 5-HT2C receptors; however, the effects of 5-HT2C receptor ligands on neuronal physiology are unclear. 5-HT2C receptor agonism decreases psychostimulant-mediated behaviors, and the putative 5-HT2C receptor inverse agonist, SB 206553, attenuates methamphetamine-seeking in rats. To ascertain the effects of methamphetamine, and 5-HT2C receptor inverse agonism and agonism, on neuronal function in the nucleus accumbens, we evaluated methamphetamine, SB 206553, and the 5-HT2C receptor agonist and Ro 60-0175, on neuronal excitability within the accumbens shell subregion using whole-cell current-clamp recordings in forebrain slices ex vivo. We reveal that methamphetamine self-administration decreased generation of evoked action potentials. In contrast, SB 206553 and Ro 60-0175 increased evoked spiking, effects that were prevented by the 5-HT2C receptor antagonist, SB 242084. We also assessed signaling mechanisms engaged by 5-HT2C receptors, and determined that accumbal 5-HT2C receptors stimulated Gq, but not Gi/o. These findings demonstrate that methamphetamine-induced decreases in excitability of neurons within the nucleus accumbens shell were abrogated by both 5-HT2C inverse agonism and agonism, and this effect likely involved activation of Gq-mediated signaling pathways.

Indexed as

Drug Inverse AgonismAnimalsMaleMethamphetamineNucleus AccumbensRatsRats, Sprague-DawleyReceptor, Serotonin, 5-HT2CSelf AdministrationSerotonin 5-HT2 Receptor AgonistsMethamphetamineReceptor, Serotonin, 5-HT2CSerotonin 5-HT2 Receptor Agonists5-HT(2C)Constitutive activityInverse agonistMethamphetamineNucleus accumbensSerotonin

Identifiers

PMID25229719
PMCPMC4321813
OpenAlexW2013573314

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.